Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/19/2000 | WO2000061621A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
10/19/2000 | WO2000061620A1 49 human secreted proteins |
10/19/2000 | WO2000061617A2 Transiently immortalized cells for use in gene therapy |
10/19/2000 | WO2000061614A2 Uncoupling proteins |
10/19/2000 | WO2000061612A2 Compounds and methods for therapy and diagnosis of lung cancer |
10/19/2000 | WO2000061606A1 Novel human voltage-gated potassium channel |
10/19/2000 | WO2000061596A1 50 human secreted proteins |
10/19/2000 | WO2000061156A2 Methods of treating schizophrenia |
10/19/2000 | WO2000060932A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
10/19/2000 | WO2000036093A3 Intein-mediated cyclization of peptides |
10/19/2000 | WO2000034485A3 Beta-1,3-galactosyltransferase homologs |
10/19/2000 | WO2000034308A3 Protein transduction system and methods of use thereof |
10/19/2000 | WO2000032778A3 Methods and compositions for inhibiting neoplastic cell growth |
10/19/2000 | WO2000032769A3 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
10/19/2000 | WO2000032224A3 Calcitonin for the modulation of sperm function |
10/19/2000 | WO2000029551A3 Cells, culture methods, and their use in autologous transplantation therapy |
10/19/2000 | WO2000029550A9 Low oxygen culturing of central nervous system progenitor cells |
10/19/2000 | WO2000028008B1 Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
10/19/2000 | WO2000024437A3 Textured and porous silicone rubber |
10/19/2000 | WO2000012720A8 Elongase genes and uses thereof |
10/19/2000 | DE19915610A1 Verfahren zur Besiedlung von Substraten mit biologischen Zellen und dafür verwendbare Besiedlungsvorrichtungen Method for colonization of substrates with biological cells and used therefor settlement devices |
10/19/2000 | DE19915057A1 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung Monoclonal antibodies to human protein Mcm3, processes for their preparation and their use |
10/19/2000 | CA2760534A1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
10/19/2000 | CA2704600A1 A method for producing antibodies with increased adcc activity |
10/19/2000 | CA2372028A1 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
10/19/2000 | CA2371223A1 49 human secreted proteins |
10/19/2000 | CA2371172A1 50 human secreted proteins |
10/19/2000 | CA2370767A1 49 human secreted proteins |
10/19/2000 | CA2370562A1 49 human secreted proteins |
10/19/2000 | CA2370523A1 49 human secreted proteins |
10/19/2000 | CA2370489A1 49 human secreted proteins |
10/19/2000 | CA2370189A1 48 human secreted proteins |
10/19/2000 | CA2370131A1 62 human secreted proteins |
10/19/2000 | CA2370112A1 Uncoupling proteins |
10/19/2000 | CA2369892A1 Method for quantifying transforming growth factor-.beta.1 and method for detecting cancer by using same |
10/19/2000 | CA2369822A1 Novel human voltage-gated potassium channel |
10/19/2000 | CA2369578A1 Compounds and methods for therapy and diagnosis of lung cancer |
10/19/2000 | CA2369439A1 Methods of treating schizophrenia |
10/19/2000 | CA2369413A1 Transmembrane protein expressed in prostate and other cancers |
10/19/2000 | CA2369156A1 Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding 4e-bp1 |
10/19/2000 | CA2366543A1 Multistage electromagnetic separator for purifying cells, chemicals and protein structures |
10/19/2000 | CA2366520A1 Anti-bacterial vaccine compositions |
10/19/2000 | CA2365918A1 49 human secreted proteins |
10/19/2000 | CA2365917A1 Bone morphogenic proteins |
10/19/2000 | CA2365916A1 Novel lipoxygenase proteins and polynucleotides encoding the same |
10/19/2000 | CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
10/19/2000 | CA2365914A1 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
10/19/2000 | CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same |
10/19/2000 | CA2365912A1 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
10/19/2000 | CA2365910A1 Human proteins and polynucleotides encoding them |
10/19/2000 | CA2365908A1 Reagents and methods for identifying and modulating expression of genes regulated by p21 |
10/19/2000 | CA2365906A1 Carotene hydroxylase and method for producing xanthophyll derivatives |
10/19/2000 | CA2365905A1 48 human secreted proteins |
10/19/2000 | CA2365623A1 Tyrosine kinase substrate (tks) proteins |
10/19/2000 | CA2365522A1 48 human secreted proteins |
10/19/2000 | CA2364577A1 Regulation of repressor genes using nucleic acid molecules |
10/19/2000 | CA2364570A1 Preparing porous hydrogel products |
10/19/2000 | CA2364565A1 Glucose dehydrogenases |
10/19/2000 | CA2364541A1 Genes associated with diseases of the kidney |
10/19/2000 | CA2360318A1 A second mammalian tankyrase |
10/18/2000 | EP1045024A1 Use of human hepatocyte cell line for the treatment of chronic or acute liver failure |
10/18/2000 | EP1045023A1 Serum free medium |
10/18/2000 | EP1044605A1 Gene mutant animals |
10/18/2000 | EP1044279A1 Plants with modified growth |
10/18/2000 | EP1044277A2 Recombinant, active caspases and uses thereof |
10/18/2000 | EP1044275A1 Mammalian matrix-type metalloprotease |
10/18/2000 | EP1044273A2 COMPOSITIONS DERIVED FROM $i(MYCOBACTERIUM VACCAE) AND METHODS FOR THEIR USE |
10/18/2000 | EP1044271A1 Il-1 delta dna and polypeptides |
10/18/2000 | EP1044270A2 Apoptosis inducing molecule ii |
10/18/2000 | EP1044269A1 Human vps35/mem3-related protein |
10/18/2000 | EP1044267A2 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
10/18/2000 | EP1044266A2 Human signal peptide-containing proteins |
10/18/2000 | EP1044265A1 Dna encoding a gaba br2 polypeptide and uses thereof |
10/18/2000 | EP1044263A2 CELLS EXPRESSING ANTI-Fc RECEPTOR BINDING COMPONENTS |
10/18/2000 | EP1044262A1 Sex-specific insemination of mammals with low number of sperm cells |
10/18/2000 | EP1044220A1 Secreted proteins and polynucleotides encoding them |
10/18/2000 | EP1044219A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5 |
10/18/2000 | EP1044218A1 Nucleic acids encoding transferrin receptor-like proteins and products related thereto |
10/18/2000 | EP1044217A2 Sag: sensitive to apoptosis gene |
10/18/2000 | EP1044216A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEINS, nNR7 AND nNR7-1 |
10/18/2000 | EP1044212A1 Human fk506 binding proteins |
10/18/2000 | EP1044211A1 36 human secreted proteins |
10/18/2000 | EP1044210A1 Human dendriac and brainiac-3 |
10/18/2000 | EP1044024A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
10/18/2000 | EP1044020A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
10/18/2000 | EP0876385B1 Topiramate immunoassay, as well as analogs and antibodies |
10/18/2000 | EP0577666B1 Polypeptides from mycobacterium paratuberculosis |
10/18/2000 | EP0467932B1 Urokinase-type plasminogen activator receptor |
10/18/2000 | CN1270634A Vertebrate telomerase genes and proteins and uses thereof |
10/18/2000 | CN1270632A APPIL-a novel protein with growth effects |
10/18/2000 | CN1270630A Method of treating leukocytes, leukocyte compositions and methods of use thereof |
10/18/2000 | CN1270497A Toxin genes from the bacteria i (xenorhabdus nematophilus) and i (photorhabdus luminescens) |
10/18/2000 | CN1270061A 弯曲菌疫苗 Campylobacter vaccine |
10/18/2000 | CN1057561C Method for regulating growth of microorgans |
10/18/2000 | CN1057534C Erythropoietin analogs |
10/17/2000 | US6133435 AGL15 sequences in transgenic plants |
10/17/2000 | US6133427 Anti-human calcitonin monoclonal antibodies and an immunoassay utilizing said antibodies |
10/17/2000 | US6133423 Don-1 gene and polypeptides and uses therefor |
10/17/2000 | US6133230 Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and TGF-β, optionally in combination with IGF-1 |
10/17/2000 | US6133035 Transforming embryogenic material with agrobacterium containing gene of interest and regenerating into a plant |